1. Home
  2. ACXP vs NRT Comparison

ACXP vs NRT Comparison

Compare ACXP & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • NRT
  • Stock Information
  • Founded
  • ACXP 2017
  • NRT 1975
  • Country
  • ACXP United States
  • NRT United States
  • Employees
  • ACXP N/A
  • NRT N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • NRT Oil & Gas Production
  • Sector
  • ACXP Health Care
  • NRT Energy
  • Exchange
  • ACXP Nasdaq
  • NRT Nasdaq
  • Market Cap
  • ACXP 8.4M
  • NRT 46.4M
  • IPO Year
  • ACXP 2021
  • NRT N/A
  • Fundamental
  • Price
  • ACXP $0.45
  • NRT $4.76
  • Analyst Decision
  • ACXP Strong Buy
  • NRT
  • Analyst Count
  • ACXP 2
  • NRT 0
  • Target Price
  • ACXP $10.00
  • NRT N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • NRT 17.5K
  • Earning Date
  • ACXP 08-08-2025
  • NRT 08-29-2025
  • Dividend Yield
  • ACXP N/A
  • NRT 9.92%
  • EPS Growth
  • ACXP N/A
  • NRT 24.05
  • EPS
  • ACXP N/A
  • NRT 0.59
  • Revenue
  • ACXP N/A
  • NRT $6,184,173.00
  • Revenue This Year
  • ACXP N/A
  • NRT N/A
  • Revenue Next Year
  • ACXP N/A
  • NRT N/A
  • P/E Ratio
  • ACXP N/A
  • NRT $8.25
  • Revenue Growth
  • ACXP N/A
  • NRT 18.55
  • 52 Week Low
  • ACXP $0.30
  • NRT $3.88
  • 52 Week High
  • ACXP $3.33
  • NRT $6.90
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • NRT 41.85
  • Support Level
  • ACXP $0.45
  • NRT $4.80
  • Resistance Level
  • ACXP $0.59
  • NRT $5.20
  • Average True Range (ATR)
  • ACXP 0.08
  • NRT 0.16
  • MACD
  • ACXP -0.01
  • NRT -0.04
  • Stochastic Oscillator
  • ACXP 27.06
  • NRT 15.40

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: